Patents by Inventor John Mills
John Mills has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260137915Abstract: The present disclosure relates to macroencapsulation devices and related methods of manufacture where the membranes of a device may be mounted to an associated frame in a relaxed, or slack, configuration prior to filling with a desired material.Type: ApplicationFiled: January 12, 2026Publication date: May 21, 2026Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Danya M. Lavin, John Mills, Megan Billings
-
Publication number: 20260126453Abstract: An anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof. A method purifying an anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof.Type: ApplicationFiled: September 16, 2025Publication date: May 7, 2026Inventors: David L. MURRAY, Stephen HARDING, David R. BARNIDGE, Gregg WALLIS, John MILLS, Jamie ASHBY
-
Patent number: 12544545Abstract: The present disclosure relates to macroencapsulation devices and related methods of manufacture where the membranes of a device may be mounted to an associated frame in a relaxed, or slack, configuration prior to filling with a desired material.Type: GrantFiled: April 2, 2020Date of Patent: February 10, 2026Assignee: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Danya M. Lavin, John Mills, Megan Billings
-
Patent number: 12515028Abstract: Macroencapsulation devices and their methods of use are disclosed. In one embodiment, a macroencapsulation device may include a first outer membrane, a second outer membrane, and at least one semipermeable membrane disposed there between to form at least a primary compartment configured to house a first population of cells and a secondary compartment in fluid communication with the primary compartment through the first semipermeable membrane. In some embodiments, the flow of material into and out of the compartments of the macroencapsulation device and/or the application of an appropriate pressure differential between the compartments may be used to control the flow of filtrates, ancillary agents, and other materials between the compartments of the device when positioned in vivo.Type: GrantFiled: April 2, 2020Date of Patent: January 6, 2026Assignee: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, John Mills, Megan Billings
-
Patent number: 12461108Abstract: An anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof. A method purifying an anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof.Type: GrantFiled: February 24, 2017Date of Patent: November 4, 2025Assignees: THE BINDING SITE GROUP LIMITED, MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHInventors: David L. Murray, Stephen Harding, David R. Barnidge, Gregg Wallis, John Mills, Jamie Ashby
-
Publication number: 20250319295Abstract: Provided herein are devices, systems, and methods for subcutaneous membrane, encapsulation chamber, or reservoir implantation comprising or employing an implantation device configured to insert a membrane, encapsulation chamber, or reservoir into a subject.Type: ApplicationFiled: June 27, 2025Publication date: October 16, 2025Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Moses Goddard, Moses Sandrof, John Mills, Megan Billings
-
Publication number: 20250305289Abstract: A reinforcing bar guide assembly includes a guide structure, a first securing structure, and a second securing structure. The guide structure is designed to be placed over an opening in a building component, such as a cinder block or masonry brick, into which a reinforcing bar is to be inserted. The guide structure includes a guide orifice designed and positioned to receive and hold a reinforcing bar in an essentially vertical orientation. The first securing structure and the second securing structure are designed to be placed onto outer edges of a building component to support and hold the guide structure in a desired position over an opening in a building component.Type: ApplicationFiled: March 28, 2024Publication date: October 2, 2025Inventor: John Mills
-
Patent number: 12377252Abstract: Provided herein are devices, systems, and methods for subcutaneous membrane, encapsulation chamber, or reservoir implantation comprising or employing an implantation device configured to insert a membrane, encapsulation chamber, or reservoir into a subject.Type: GrantFiled: March 12, 2019Date of Patent: August 5, 2025Assignee: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Moses Goddard, Moses Sandrof, John Mills, Megan Billings
-
Publication number: 20250236445Abstract: A novel thermoplastic baling wire suitable for baling waste destined for either recycling or for refuse derived fuel, having recyclable properties and good self-knotting properties comprises recycled thermoplastic material is polyethylene terephthalate comprising 6%±2% by weight of polyethylene. A method of manufacture of said baling wire comprises preparing a masterbatch of recycled polyethylene terephthalate (rPET) including one or more multi-functional acrylic oligomers to obtain a modified recycled polyethylene terephthalate; combining said modified rPET with a phthalocyanine based nucleating agent; transitioning said modified rPET from molten to solid state; and extruding said modified rPET material into an elongate band.Type: ApplicationFiled: February 1, 2024Publication date: July 24, 2025Inventors: Peter James ROBINSON, Matthew David ROBINSON, John MILLS
-
Publication number: 20250025210Abstract: Macroencapsulation implantation devices and containers for storing a macroencapsulation device disposed within a receptacle of a macroencapsulation implantation device as well as related methods are described. In some embodiments, a macroencapsulation implantation device may include a handle that is configured to be selectively engaged with a receptacle including a recess in which a macroencapsulation device may be disposed. In some embodiments, a container may be configured to maintain a receptacle of a macroencapsulation implantation device, and a macroencapsulation device disposed therein, in a desired pose within an internal volume of the container.Type: ApplicationFiled: July 19, 2024Publication date: January 23, 2025Applicant: Vertex Pharmaceuticals IncorporatedInventors: Megan Billings, John Mills, John Fraser Mills, Noah Nguyen, Christopher Thanos
-
Publication number: 20240352392Abstract: Macroencapsulation devices and related methods of manufacture are described where bonded membranes of a device may be mounted to an associated frame in an arrangement to provide stress relief between the frame and a seal perimeter of the bonded membranes. The seal perimeter may be arranged radially inward from an outer perimeter of the membranes such that when the membranes are mounted to a corresponding perimeter frame, the seal perimeter is spaced radially inwards from the frame with a unbonded portion of the one or more membranes disposed between the frame and seal perimeter.Type: ApplicationFiled: August 16, 2022Publication date: October 24, 2024Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, John Mills, Matthew Watson, Rahul R. Rajendran, Noah Nguyen
-
Publication number: 20240342077Abstract: The present disclosure provides a cell housing device and a method of manufacturing such a device that has an array of chemicals to increase the ratio of surface area to volume.Type: ApplicationFiled: September 21, 2023Publication date: October 17, 2024Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Danya M. Lavin, Briannan E. Bintz, Divya Bhatnagar, John Mills, Megan Billings
-
Publication number: 20240148642Abstract: The present disclosure provides a cell housing device and a method of manufacturing such a device that has an array of channels to increase the ratio of surface area to volume.Type: ApplicationFiled: January 18, 2024Publication date: May 9, 2024Applicant: Vertex Pharmaceuticals IncorporatedInventors: CHRISTOPHER THANOS, Danya M. Lavin, Briannan E. Bintz, Divya Bhatnagar, John Mills, Megan Billings
-
Patent number: 11951206Abstract: The present disclosure provides a cell housing device and a method of manufacturing such a device that has an array of channels to increase the ratio of surface area to volume.Type: GrantFiled: September 29, 2018Date of Patent: April 9, 2024Assignee: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Danya M. Lavin, Briannan E. Bintz, Divya Bhatnagar, John Mills, Megan Billings
-
Publication number: 20240033216Abstract: The present disclosure provides a cell housing device and a method of manufacturing such a device that has an array of chemicals to increase the ratio of surface area to volume.Type: ApplicationFiled: September 21, 2023Publication date: February 1, 2024Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Danya M. Lavin, Briannan E. Bintz, Divya Bhatnagar, John Mills, Megan Billings
-
Publication number: 20220175511Abstract: The present disclosure relates to macroencapsulation devices and related methods of manufacture where the membranes of a device may be mounted to an associated frame in a relaxed, or slack, configuration prior to filling with a desired material.Type: ApplicationFiled: April 2, 2020Publication date: June 9, 2022Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Danya M. Lavin, John Mills, Megan Billings
-
Publication number: 20220143374Abstract: Macroencapsulation devices and their methods of use are disclosed. In one embodiment, a macroencapsulation device may include a first outer membrane, a second outer membrane, and at least one semipermeable membrane disposed there between to form at least a primary compartment configured to house a first population of cells and a secondary compartment in fluid communication with the primary compartment through the first semipermeable membrane. In some embodiments, the flow of material into and out of the compartments of the macroencapsulation device and/or the application of an appropriate pressure differential between the compartments may be used to control the flow of filtrates, ancillary agents, and other materials between the compartments of the device when positioned in vivo.Type: ApplicationFiled: April 2, 2020Publication date: May 12, 2022Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, John Mills, Megan Billings
-
Publication number: 20210016073Abstract: Provided herein are devices, systems, and methods for subcutaneous membrane, encapsulation chamber, or reservoir implantation comprising or employing an implantation device configured to insert a membrane, encapsulation chamber, or reservoir into a subject.Type: ApplicationFiled: March 12, 2019Publication date: January 21, 2021Applicant: Vertex Pharmaceuticals IncorporatedInventors: Christopher Thanos, Moses Goddard, Moses Sandrof, John Mills, Megan Billings
-
Publication number: 20200289407Abstract: The present disclosure provides a cell housing device and a method of manufacturing such a device that has an array of channels to increase the ratio of surface area to volume.Type: ApplicationFiled: September 29, 2018Publication date: September 17, 2020Applicant: Semma Therapeutics, Inc.Inventors: Christopher Thanos, Danya M. Lavin, Briannan E. Bintz, Divya Bhatnagar, John Mills, Megan Billings
-
Publication number: 20190094239Abstract: An anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof. A method purifying an anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof.Type: ApplicationFiled: February 24, 2017Publication date: March 28, 2019Inventors: David L. MURRAY, Stephen HARDING, David R. BARNIDGE, Gregg WALLIS, John MILLS, Jamie ASHBY